Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 375, Issue 3, 2007, Pages 157-175

  Di Paola, Rosanna ^a,b   Cuzzocrea, Salvatore ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

Ischemia; Peroxisome proliferator activated receptors; Reperfusion tissue injury

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; FIBRIC ACID DERIVATIVE; GLITAZONE DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PIRINIXIC ACID; PROSTAGLANDIN; ROSIGLITAZONE; TROGLITAZONE;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BRAIN ISCHEMIA; GLUCOSE METABOLISM; HEART MUSCLE ISCHEMIA; HUMAN; INTESTINE ISCHEMIA; ISCHEMIA; KIDNEY ISCHEMIA; LIPID METABOLISM; LIVER INJURY; LUNG ISCHEMIA; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; REPERFUSION INJURY; REVIEW;

ANIMALS; BRAIN DISEASES; HUMANS; KIDNEY DISEASES; LIGANDS; LIVER DISEASES; LUNG DISEASES; MODELS, BIOLOGICAL; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; REPERFUSION INJURY;

EID: 34047168224     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-007-0141-2     Document Type: Review

References (191)

1. Abdelrahman M, Sivarajah A, Thiemermann C (2005) Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock. Cardiovasc Res 65:772-781
2. Abraham D, Taghavi S, Riml P, Paulus P, Hofmann M, Baumann C, Kocher A, Klepetko W, Aharinejad S (2002) VEGF-A and -C but not -B mediate increased vascular permeability in preserved lung grafts. Transplantation 73:1703-1706
3. Al Mehdi AB, Shuman H, Fisher AB (1997) Intracellular generation of reactive oxygen species during nonhypoxic lung ischemia. Am J Physiol 272:L294-L300
4. Al Mehdi AB, Zhao G, Fisher AB (1998a) ATP-independent membrane depolarization with ischemia in the oxygen-ventilated isolated rat lung. Am J Respir Cell Mol Biol 18:653-661
5. Al Mehdi AB, Zhao G, Dodia C, Tozawa K, Costa K, Muzykantov V, Ross C, Blecha F, Dinauer M, Fisher AB (1998b) Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+Circ Res 83:730-737
6. Ames A III (1968) Cerebral ischemia II. The no-reflow phenomenon. Amer J Pathol 52:437-453
7. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730-732
8. Arany I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23:460-464
9. Argmann CA, Cock TA, Auwerx J (2005) Peroxisome proliferator-activated receptor gamma: the more the merrier? Eur J Clin Invest 35:82-92
10. Attuwaybi BO, Kozar RA, Moore-Olufemi SD, Sato N, Hassoun HT, Weisbrodt NW, Moore FA (2004) Heme oxygenase-1 induction by hemin protects against gut ischemia/reperfusion injury. J Surg Res 118:53-57
11. Barger PM, Kelly DP (2000) PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc Med 10:238-245
12. Berger JP, Akiyama TE, Meinke PT (2005) PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci 26:244-251
13. Bloomfield Rubins H (2001) Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). Circulation 103:2828-2833
14. Bonegio R, Lieberthal W (2002) Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 11:301-308
15. Boscoe MJ, Goodwin AT, Amrani M, Yacoub MH (2000) Endothelins and the lung. Int J Biochem Cell Biol 32:41-62
16. Boulanger C, Lüscher TF (1990) Endothelin is released from the porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest 85:587-590
17. Bulhak AA, Sjoquist PO, Xu CB, Edvinsson L, Pernow J (2006) Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1. Basic Res Cardiol 101:244-252
18. Burdick AD, Kim DJ, Peraza MA, Gonzalez FJ, Peters JM (2006) The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation. Cell Signal 18(1):9-20
19. Burne-Taney MJ, Rabb H (2003) The role of adhesion molecules and T cells in ischemic renal injury. Curr Opin Nephrol Hypertens 12:85-90
20. Calnek DS, Mazzella L, Roser S, Roman J, Hart CM (2003) Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells. Arterioscler Thromb Vasc Biol 23:52-57
21. Chan KL, Zhang XH, Fung PCW, Guo WH, Tam PKH (1999) Role of nitric oxide in intestinal ischaemia-reperfusion injury studied using electron paramagnetic resonance. Br J Surg 86:1427-1432
22. Chatterjee PK (2004) The cyclopentenone prostaglandin 15-deoxy-delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure. Cardiovasc Res 61:630-643
23. Chung BH (2005) Protective effect of peroxisome proliferator activated receptor gamma agonists on diabetic and non-diabetic renal diseases. Nephrology (Carlton) 10(Suppl 2):S40-S43
24. Collino M, Aragno M, Mastrocola R, Benetti E, Gallicchio M, Dianzani C, Danni O, Thiemermann C, Fantozzi R (2006a) Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643. Free Radic Biol Med 41:579-589
25. Collino M, Aragno M, Mastrocola R, Gallicchio M, Rosa AC, Dianzani C, Danni O, Thiemermann C, Fantozzi R (2006b) Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur J Pharmacol 530:70-80
26. Cook SA, Matsui T, Li L, Rosenzweig A (2002) Transcriptional effects of chronic Akt activation in the heart. J Biol Chem 277:22528-22533
27. Cuzzocrea S (2003) Rosiglitazone and 15-deoxy-delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. Br J Pharmacol 140:366-376
28. Cuzzocrea S (2004a) Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury. Vascul Pharmacol 41:187-195
29. Cuzzocrea S (2004b) WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock. Shock 22:340-346
30. Cuzzocrea S, Zingarelli B, Caputi AP (1998) Role of constitutive nitric oxide synthase and peroxynitrite production in a rat model of splanchnic artery occlusion shock. Life Sci 63:789-799
31. Cuzzocrea S, Chatterjee P, Mazzon E, Dugo L, De Sarro A, Van de Loo FAJ, Caputi AP, Thiemermann C (2002) Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury. Shock 18:169-176
32. Cuzzocrea S, Rossi A, Serraino I, Di Paola R, Dugo L, Genovese T, Caputi AP, Sautebin L (2003) 5-Lipoxygenase knockout mice exhibit a resistance to splanchnic artery occlusion shock. Shock 20:230-236
33. Date H, Matsumura A, Manchester JK, Obo H, Lima O, Cooper JM, Sundaresan S, Lowry OH, Cooper JD (1993) Evaluation of lung metabolism during successful twenty-four-hour canine lung preservation. J Thorac Cardiovasc Surg 105:480-491
34. Delea TE, Edelsberg JS, Hagiwara M, Oster G, Phillips LS (2003) Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study. Diabetes Care 26:2983-2989
35. Delerive P, Martin-Nizard F, Chinetti G, Trottein F, Fruchart JC, Najib J, Duriez P, Staels B (1999) Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway. Circ Res 85:394-402
36. Demertzis S, Langer F, Graeter T, Dwenger A, Georg T, Schafers HJ (1999) Amelioration of lung reperfusion injury. Eur J Cardiothorac Surg 16:174-180
37. Denecker G, Vercammen D, Declercq W, Vandenabeele P (2001) Apoptotic and necrotic cell death induced by death domain receptors. Cell Mol Life Sci 58:356-370
38. Deplanque D (2003) Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J Neurosci 23:6264-6271
39. Despres JP, Lemieux I, Robins SJ (2004) Role of fibric acid derivatives in the management of risk factors for coronary heart disease. Drugs 64:2177-2198
40. Desvergne B, Michalik L, Wahli W (2004) Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Mol Endocrinol 18:1321-1332
41. Dewald O, Sharma S, Adrogue J, Salazar R, Duerr GD, Crapo JD, Entman ML, Taegtmeyer H (2005) Downregulation of peroxisome proliferator-activated receptor-alpha gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species and prevents lipotoxicity. Circulation 112:407-415
42. Diemer NH, Johansen FF, Benveniste H (1993) Ischemia as an excitotoxic lesion: protection against hippocampal neuron loss by denervation. Acta Neurochir Suppl 57:94-101
43. Ding G, Cheng L, Qin Q, Frontin S, Yang Q (2006) PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes. J Mol Cell Cardiol 40:821-828
44. Donnahoo KK, Meldrum DR, Shenkar R, Chung CS, Abraham E, Harken AH (2000) Early renal ischemia, with or without reperfusion, activates NF-κB and increases TNF-α bioactivity in the kidney. J Urol 163:1328-1332
45. Dormandy JA (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366:1279-1289
46. Elsharkawy AM, Oakley F, Mann DA (2005) The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 10:927-939
47. Engler R (1987) Consequences of activation and adenosine mediated inhibition of granulocytes during myocardial ischemia. Federation Proc 46:2407-412
48. Fiorucci S (2005) Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. J Pharmacol Exp Ther 315:58-68
49. Fischer S, Cassivi SD, Xavier AM, Cardella JA, Cutz E, Edwards V, Liu M, Keshavjee S (2000) Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation. Ann Surg 231:424-431
50. Fisher AB, Dodia C, Tan ZT, Ayene I, Eckenhoff RG (1991) Oxygen-dependent lipid peroxidation during lung ischemia. J Clin Invest 88:674-679
51. Fragasso G (2003) Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy. Am Heart J 146:E18
52. Frangogiannis NG, Smith CW, Entman ML (2002) The inflammatory response in myocardial infarction. Cardiovasc Res 53:31-47
53. Frank MM (1987) Complement in the pathophysiology of human disease. N Engl J Med 316:1525-1530
54. Fredenrich A, Grimaldi PA (2005) PPAR delta: an uncompletely known nuclear receptor. Diabetes Metab 31:23-27
55. Fruchart JC, Staels B, Duriez P (2001) The role of fibric acids in atherosclerosis. Curr Atheroscler Rep 3:83-92
56. Galli A (2002) Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 122:1924-1940
57. Gerlach J, Jorres A, Nohr R, Zeilinger K, Spatkowski G, Neuhaus P (1999) Local liberation of cytokines during liver preservation. Transpl Int 12:261-265
58. Giannini S, Serio M, Galli A (2004) Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity. J Endocrinol Invest 27:982-991
59. Gobe G, Zhang XJ, Willgoss DA, Schoch E, Hogg NA, Endre ZH (2000) Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 11:454-467
60. Gonon AT, Gourine AV, Pernow J (2000) Cardioprotection from ischemia and reperfusion injury by an endothelin A receptor antagonist in relation to nitric oxide production. J Cardiovasc Pharmacol 36:405-412
61. Gonon AT, Gourine AV, Middelveld RJ, Alving K, Pernow J (2001) Limitation of infarct size and attenuation of myeloperoxidase activity by an endothelin A receptor antagonist following ischemia and reperfusion. Basic Res Cardiol 96:454-462
62. Gonon AT, Bulhak A, Labruto F, Sjoquist PO, Pernow J (2007) Cardioprotection mediated by rosiglitazone, a peroxisome proliferatoractivated receptor gamma ligand, in relation to nitric oxide. Basic Res Cardiol 102:80-89
63. Goto M, Takei Y, Kawano S, Nagano K, Tsuji S, Masuda E, Nishimura Y, Okumura S, Kashiwagi T, Fusamoto H, Kamada T (1994) Endothelin-1 involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances. Hepatology 19:675-681
64. Grace PA (1994) Ischaemia-reperfusion injury. Br J Surg 81:637-647
65. Granger DN (1988) Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 255:H1269-H1275
66. Granger DN, Kubes P (1994) The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 55:662-675
67. Granger DN, Hollwarth ME, Parks DA (1986) Ischemia-reperfusion injury: role of oxygen-derived free radicals. Acta Physiol Scand Suppl 548:47-63
68. Grattagliano I, Vendemiale G, Lauterburg BH (1999) Reperfusion injury of the liver: role of mitochondria and protection by glutathione ester. J Surg Res 86:2-8
69. Guan Y (2004) Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome. J Am Soc Nephrol 15:2801-2815
70. Guder WG, Ross BD (1984) Enzyme distribution along the nephron. Kidney Int 26:101-111
71. Hellemans K (2003) Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells. Gastroenterology 124:184-201
72. Hertz L (1981) Features of astrocyte function apparently involved in the response of central nervous tissue to ischemia-hypoxia. J Cereb Blood Flow Metab 1:143-153
73. Heuser D, Guggenberger H (1985) Ionic changes in brain ischemia and alterations produced by drugs. Br J Anesth 57:23
74. Hisama N, Yamaguchi Y, Ishiko T, Miyanari N, Ichiguchi O, Goto M, Mori K, Watanabe K, Kawamura K, Tsurufuji S, Ogawa M (1996) Kupffer cell production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion injury in rats. Hepatology 24:1193-1198
75. Homeister JW, Lucchesi BR (1994) Complement activation and inhibition in myocardial ischemia and reperfusion injury. Annu Rev Pharmacol Toxicol 34:17-40
76. Ichikawa H (2002) A specific peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand, pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats. Redox Rep 7:343-346
77. Inoue H (2003) Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice. Neurosci Lett 352:203-206
78. Iredale JP (2003) Cirrhosis: new research provides a basis for rational and targeted treatments. BMJ 327:143-147
79. Ishibashi N, Weisbrot-Lefkowitz M, Reuhl K, Inouye M, Morichnitchenko O (1999) Modulation of chemokine expression during ischemia/reperfusion in transgenic mice overproducing human glutathione peroxidases. J Immunol 163:5666-5677
80. Israelian-Konaraki Z, Reaven PD (2005) Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications. Cardiology 103:1-9
81. Ito K (2004) Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats. Eur J Cardiothorac Surg 25:530-536
82. Jaeschke H (1998) Mechanism of reperfusion injury after warm ischemia of the liver. J Hepatol 21:402-408
83. Jaeschke H, Farhood A (1991) Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver in vivo. Am J Physiol Gastrointest Liver Physiol 260:G355-G362
84. Jaeschke H, Farhood A, Smith CW (1990) Neutrophils contribute to ischemia-reperfusion injury in rat liver in vivo. FASEB J 4:3355-3359
85. Jaeschke H, Bautista AP, Spolarics Z, Spitzer JJ (1992) Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J Leukoc Biol 52:377-382
86. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ (1993) Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol Gastrointest Liver Physiol 264:G801-G809
87. James EJ, Zhao ZQ, Vinten-Johansen J (1999) The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43:860-878
88. Jonas S (1995) Prophylactic pharmacologic neuroprotection against focal cerebral ischemia. Ann NY Acad Sci 765:21-25
89. Kalimo H, Garcia JH, Kamijyo Y (1977) The ultrastructure of brain death II. Electron microscopy of feline cortex after complete ischemia. Virchow's Arch B Cell Path 25:207-220
90. Kantor PF, Lucien A, Kozak R, Lopaschuk GD (2000) The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 86:580-588
91. Kaplan J, Dimlich RVW, Biros MH, Hesges J (1987) Mechanisms of ischemic cerebral injury. Resuscitation 15:149-169
92. Karlsson U, Schultz RL (1966) Fixation of the central nervous system for electron microscopy by aldehyde perfusion. III. Structural changes after exsanguination and delayed perfusion. J Ultrastruc Res 14:57-63
93. Karol AK, Bonda TA, Korecki J, Wlodzimierz JM (2002) Oxidative stress and neutrophil activation-the two keystones of ischemia-reperfusion injury. Int J Cardiol 86:41-59
94. Kelly RF (2000) Current strategies in lung preservation. J Lab Clin Med 136:427-440
95. Kelly KJ, Tolkoff-Rubin NE, Rubin RH, Williams WW Jr, Meehan SM, Meschter CL, Christenson JG, Bonventre JV (1996a) An oral platelet-activating factor antagonist, Ro-24-4736, protects the rat kidney from ischemic injury. Am J Physiol Renal Fluid Electrolyte Physiol 271:F1061-F1067
96. Kelly KJ, Williams WW Jr, Colvin RB, Meehan SM, Springer TA, Gutiérrez-Ramos JC, Bonventre JV (1996b) Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 97:1056-1063
97. Khandoudi N, Delerive P, Berrebi-Bertrand I, Buckingham RE, Staels B, Bril A (2002) Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury. Diabetes 51:1507-1514
98. King RC (2000) Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 69:1681-1685
99. Kips JC (2001) Cytokines in asthma. Eur Respir J Suppl 34:24s-33s
100. Kosonen O, Kankaanranta H, Malo-Ranta U, Moilanen E (1999) Nitric oxide-releasing compounds inhibit neutrophil adhesion to endothelial cells. Eur J Pharmacol 382:111-117
101. Kourembanas S, Marsden PA, McQuillan LP, Faller DV (1991) Hypoxia induces endothelin expression and secretion in cultured human endothelium. J Clin Invest 88:1054-1057
102. Kumamoto Y, Suematsu M, Shimazu M, Kato Y, Sano T, Makino N, Hirano KI, Naito M, Wakabayashi G, Ishimura Y, Kitajima M (1999) Kupffer cell-independent acute hepatocellular oxidative stress and decreased bile formation in post-cold-ischemic rat liver. Hepatology 30:1454-1463
103. Kuwano K, Hara N (2000) Signal transduction pathways of apoptosis and inflammation induced by the tumor necrosis factor receptor family. Am J Respir Cell Mol Biol 22:147-149
104. Lansman JB (1988) Endothelial mechanosensors: going with the flow. Nature 331:481-482
105. Lee TM, Chou TF (2003) Troglitazone administration limits infarct size by reduced phosphorylation of canine myocardial connexin43 proteins. Am J Physiol Heart Circ Physiol 285:H1650-H1659
106. Lemay S, Rabb H, Postler G, Singh AK (2000) Prominent and sustained up-regulation of gp130-signaling cytokines and the chemokine MIP-2 in murine renal ischemia-reperfusion injury. Transplantation 69:959-963
107. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ (1998) Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology 27:507-512
108. Letavernier E, Perez J, Joye E, Bellocq A, Fouqueray B, Haymann JP, Heudes D, Wahli W, Desvergne B, Baud L (2005) Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure. J Am Soc Nephrol 16:2395-2402
109. Li S (2004) PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G. Am J Physiol Renal Physiol 287:F990-F998
110. Li JM, Shah AM (2001) Differential NADPH- versus NADH-dependent superoxide production by phagocyte-type endothelial cell NADPH oxidase. Cardiovasc Res 52:477-486
111. Li S, Gokden N, Okusa MD, Bhatt R, Portilla D (2005) Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF. Am J Physiol Renal Physiol 289:F469-F480
112. Liu HR (2004) Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion. Cardiovasc Res 62:135-144
113. Liu P, Fisher MA, Farhood A, Smith CW, Jaeschke H (1994) Beneficial effects of extracellular glutathione against endotoxin-induced liver injury during ischemia and reperfusion. Circ Shock 43:64-70
114. Luquet S, Gaudel C, Holst D, Lopez-Soriano J, Jehl-Pietri C, Fredenrich A, Grimaldi PA (2005) Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes. Biochim Biophys Acta 1740:313-317
115. Luster AD (1998) Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338:436-445
116. Marra F (2005) Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis. World J Gastroenterol 11:4931-4938
117. McCord JM (1985) Oxygen derived free radicals in postischemic tissue injury. N Eng J Med 312:159-163
118. McCuskey RS (2000) Morphological mechanisms for regulating blood flow through hepatic sinusoids. Liver 20:3-7
119. Meldrum DR (1998) Tumor necrosis factor in the heart. Am J Physiol Regul Integr Comp Physiol 274 (3Pt2):R577-R595
120. Minamiya Y, Tozawa K, Kitamura M, Saito S, Ogawa J (1998) Platelet-activating factor mediates intercellular adhesion molecule-1-dependent radical production in the nonhypoxic ischemia rat lung. Am J Respir Cell Mol Biol 19:150-157
121. Molavi B, Chen J, Mehta JL (2006) Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK. Am J Physiol Heart Circ Physiol 291:H687-H693
122. Molitoris BA, Sutton TA (2004) Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int 66:496-499
123. Monaghan DT, Holets RV, Toy DW, Cotman CW (1983) Anatomical distributions of four pharmacologically distinct 3H-glutamate binding sites. Nature 306:176-179
124. Montalto MC, Hart ML, Jordan JE, Wada K, Stahl GL (2003) Role for complement in mediating intestinal nitric oxide synthase-2 and superoxide dismutase expression. Am J Physiol 285:G197-G206
125. Muia C, Mazzon E, Crisafulli C, Di Paola R, Genovese T, Caputi AP, Cuzzocrea S (2006) Role of endogenous peroxisome proliferator-activated receptor-alpha (PPAR-alpha) ligands in the development of gut ischemia and reperfusion in mice. Shock 25:17-12
126. Mullane KM, Salmon JA, Kraemer R (1987) Leukocyte derived metabolites of arachidonic acid in ischemia-induced myocardial injury. Federation Proc 46:2422-2433
127. Naito Y, Takagi T, Uchiyama K, Handa O, Tomatsuri N, Imamoto E, Kokura S, Ichikawa H, Yoshida N, Yoshikawa T (2002) Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-gamma ligand pioglitazone in rats. Redox Rep 7:294-299
128. Naka Y, Marsh HC, Scesney SM, Oz MC, Pinsky DJ (1997) Complement activation as a cause for primary graft failure in an isogeneic rat model of hypothermic lung preservation and transplantation. Transplantation 64:1248-1255
129. Nakajima A (2001) Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 120:460-469
130. Nakamura S, Nishiyama R, Serizawa A, Yokoi Y, Suzuki S, Konno H, Baba S, Muro H (1995) Hepatic release of endothelin-1 after warm ischemia. Transplantation 59:679-684
131. Oberbauer R, Rohrmoser M, Regele H, Muhlbacher F, Mayer G (1999) Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol 10:2006-2013
132. Okada M, Yan SF, Pinsky DJ (2002) Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets. FASEB J 16:1861-1868
133. Okaya T, Lentsch AB (2004) Peroxisome proliferator-activated receptor-alpha regulates postischemic liver injury. Am J Physiol Gastrointest Liver Physiol 286:G606-G612
134. Okuaki Y, Miyazaki H, Zeniya M, Ishikawa T, Ohkawa Y, Tsuno S, Sakaguchi M, Hara M, Takahashi H, Toda G (1996) Splenectomy-reduced hepatic injury induced by ischemia/reperfusion in the rat. Liver 16:188-194
135. Onody A, Zvara A, Hackler L Jr, Vigh L, Ferdinandy P, Puskas LG (2003) Effect of classic preconditioning on the gene expression pattern of rat hearts:a DNA microarray study. FEBS Lett 536:35-40
136. Oz MC, Liao H, Naka Y, Seldomridge A, Becker DN, Michler RE, Smith CR, Rose EA, Stern DM, Pinsky DJ (1995) Ischemia-induced interleukin-8 release after human heart transplantation: a potential role for endothelial cells. Circulation 92:II428-II432
137. Ozaki M, Deshpande SS, Angkeow P, Bellan J, Lowenstein CJ, Dinauer MC, Goldschmidt-Clermont PJ, Irani K (2000) Inhibition of the Rac1 GTPase protects against nonlethal ischemia/reperfusion-induced necrosis and apoptosis in vivo. FASEB J 14:418-429
138. Panchapakesan U, Sumual S, Pollock CA, Chen X (2005) PPAR-gamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose. Am J Physiol Renal Physiol 289: F1153-F1158
139. Parks DA, Granger DN (1986) Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol 250: G749-G753
140. Planaguma A (2005) The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. FASEB J 19:1120-1122
141. Portilla D (2000) Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure. Am J Physiol Renal Physiol 278:F667-F675
142. Reichelt KL (1978) The chemical basis for the intolerance of the brain to anoxia. Acta Anesthesiol Scand Suppl 29:35-46
143. Rhenchrona S (1985) Brain acidosis. Ann Emerg Med 14:770-776
144. Roberto A, Prado EA (2002) Ischemia/reperfusion injury. J Surg Res 105:248-258
145. Safar P (1986) Cerebral resuscitation after cardiac arrest. A review. Circulation 74(Suppl IV):138
146. Safirstein R, DiMari J, Megyesi J, Price P (1998) Mechanisms of renal repair and survival following acute injury. Semin Nephrol 18:519-522
147. Sambandam N (2006) Chronic activation of PPARalpha is detrimental to cardiac recovery following ischemia. Am J Physiol Heart Circ Physiol 290:H87-H95
148. Santos MJ (2005) Peroxisomal proliferation protects from beta-amyloid neurodegeneration. J Biol Chem 280:41057-41068
149. Sanz MJ, Johnston B, Issekutz A, Kubes P (1999) Endothelin causes P-selectin-dependent leukocyte rolling and adhesion within rat mesenteric microvessels. Am J Physiol 277:H1823-H1830
150. Sato N (2005) Differential induction of PPAR{gamma} by luminal glutamine and iNOS by luminal arginine in the rodent post ischemic small bowel. Am J Physiol Gastrointest Liver Physiol. DOI 10.1152/ajpgi.00248.2005
151. Sato Y, Hogg JC, English D, van Eeden SF (2000) Endothelin-1 changes polymorphonuclear leukocytes' deformability and CD11b expression and promotes their retention in the lung. Am J Respir Cell Mol Biol 23:404-410
152. Sekhon B, Sekhon C, Khan M, Patel SJ, Singh I, Singh AK (2003) N-Acetyl cysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res 971:1-8
153. Serrick C, Adoumie R, Giaid A, Shennib H (1994) The early release of interleukin-2, tumor necrosis factor-alpha and interferon-gamma after ischemia reperfusion injury in the lung allograft. Transplantation 58:1158-1162
154. Shaw MJ, Shennib H, Bousette N, Ohlstein EH, Giaid A (2001) Effect of endothelin receptor antagonist on lung allograft apoptosis and NOSII expression. Ann Thorac Surg 72:386-390
155. She H, Xiong S, Hazra S, Tsukamoto H (2005) Adipogenic transcriptional regulation of hepatic stellate cells. J Biol Chem 280:4959-4967
156. Shennib H, Lee AG, Kuang JQ, Yanagisawa M, Ohlstein EH, Giaid A (1998) Efficacy of administering an endothelin-receptor antagonist (SB209670) in ameliorating ischemia-reperfusion injury in lung allografts. Am J Respir Crit Care Med 157:1975-1981
157. Shimazu T (2005) A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia. Stroke 36:353-359
158. Siesjo BK (1981) Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab 1:155-185
159. Sivarajah A, McDonald MC, Thiemermann C (2005) The cardioprotective effects of preconditioning with endotoxin, but not ischemia, are abolished by a peroxisome proliferator-activated receptor-gamma antagonist. J Pharmacol Exp Ther 313:896-901
160. Staels B (2005) PPARgamma and atherosclerosis. Curr Med Res Opin 21:S13-S20
161. Staels B, Fruchart JC (2005) Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 54:2460-2470
162. Sundararajan S (2005) Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 130:685-696
163. Suwa T, Hogg JC, Hards J, van Eeden SF (2001) Interleukin-6 changes deformability of neutrophils and induces their sequestration in the lung. Am J Resp Crit Care Med 970-976
164. Suzuki S, Toledo-Pereyra LH (1994) Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res 57:253-258
165. Taghavi S, Abraham D, Riml P, Paulus P, Schafer R, Klepetko W, Aharinejad S (2002) Co-expression of endothelin-1 and vascular endothelial growth factor mediates increased vascular permeability in lung grafts before reperfusion. J Heart Lung Transplant 21:600-603
166. Thadhani R, Pascual M, Bonventre JV (1996) Medical progress - acute renal failure. N Engl J Med 334:1448-1460
167. Thiemermann C, Ruetten H, Wu CC, Vane JR (1995) The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116:2845-2851
168. Tien M, Aust SD (1982) Comparative aspects of several models of lipid peroxidation systems. In: Yagi K (ed) Lipid peroxides in biology and medicine. Academic Press, New York, p 23-39
169. Toyama T (2004) PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Biochem Biophys Res Commun 324:697-704
170. Turnage RH, Guice KS, Oldham KT (1994) Endotoxemia and remote organ injury following intestinal reperfusion. J Surg Res 56:571-578
171. Van Nimwegen D, Sheldon H (1966) Early postmortem changes in cerebellar neurons of the rat. J Ultrastruc Res 14:36-46
172. Vollmar B, Glasz J, Leiderer R, Post S, Menger MD (1994) Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol 145:1421-1431
173. Wada K (2004) Protective effect of endogenous PPARgamma against acute gastric mucosal lesions associated with ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 287:G452-G458
174. Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B, Chatterjee PK, Thiemermann C (2002) Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J 16:1027-1040
175. Wheeler MD (2003) Impaired Ras membrane association and activation in PPARalpha knockout mice after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol 284:G302-G312
176. Witthaut R, Farhood A, Smith CW, Jaeschke H (1994) Complement and tumor necrosis factor contribute to Mac-1 (CD11b/CD18) upregulation and systemic neutrophil activation during endotoxemia in vivo. J Leukoc Biol 55:105-111
177. Wolf G, Ziyadeh FN, Thaiss F, Tomaszewski J, Caron RJ, Wenzel U, Zahner G, Helmchen U, Stahl RA (1997) Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells: role of the antiotensin type 2 receptor. J Clin Invest 100:1047-1058
178. Xia G, Martin AE, Besner GE (2003) Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury. J Pediatr Surg 38:434-439
179. Xu J, Fu Y, Chen A (2003) Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J Physiol Gastrointest Liver Physiol 285:G20-G30
180. Xu Y, Lu L, Greyson C, Rizeq M, Nunley K, Wyatt B, Bristow MR, Long CS, Schwartz GG (2006) The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigs. Am J Physiol Heart Circ Physiol 290(5): H1798-H1807
181. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y,
182. Yavrom S (2005) Peroxisome proliferator-activated receptor gamma suppresses proximal alpha 1(I) collagen promoter via inhibition of p300-facilitated NF-I binding to DNA in hepatic stellate cells. J Biol Chem 280:40650-40659
183. Yokoyama Y, Baveja R, Sonin N, Nakanishi K, Zhang JX, Clemens MG (2000) Altered endothelin receptor subtype expression in hepatic injury after ischemia/reperfusion. Shock 13:72-78
184. Yue TL (2003) Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury. Circulation 108:2393-2399
185. Zhang B, Borderie D, Sogni P, Soubrane O, Houssin D, Calmus Y (1997) NO-mediated vasodilation in the rat liver. Role of hepatocytes and liver endothelial cells. J Hepatol 26:1348-1355
186. Zhao G, Al Mehdi AB, Fisher AB (1997) Anoxia-reoxygenation versus ischemia in isolated rat lungs. Am J Physiol 273:L1112-L1117
187. Zhao Y, Patzer A, Gohlke P, Herdegen T, Culman J (2005) The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain. Eur J Neurosci 22:278-282
188. Zhao Y, Patzer A, Herdegen T, Gohlke P, Culman J (2006) Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats. FASEB J 20(8):1162-1175
189. Zimmermann KC, Bonzon C, Green DR (2001) The machinery of programmed cell death. Pharmacol Ther 92:57-70
190. Zou L, Attuwaybi B, Kone BC (2003) Effects of NF-kappa B inhibition on mesenteric ischemia-reperfusion injury. Am J Physiol 284:G713-G721
191. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt JF (1997) CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 100:279-289